Metformin‐Associated Lactic Acidosis During Docetaxel Therapy for Castration‐Resistant Prostate Cancer: A Case Report

ABSTRACT Introduction Docetaxel is a key treatment for castration‐resistant prostate cancer and is administered with prednisolone, which increases the risk of steroid‐induced diabetes. Its myelosuppressive effect also increases vulnerability to febrile neutropenia. Metformin is widely used for glyce...

詳細記述

書誌詳細

主要な著者:	Y. Inoue, A. Niimi, T. Kudo, U. Yoshizaki, Y. Sato, H. Kume
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2025-07-01
シリーズ:	IJU Case Reports
主題:	castration‐resistant prostate cancer chemotherapy metformin‐associated lactic acidosis patient education sick‐day management
オンライン･アクセス:	https://doi.org/10.1002/iju5.70055
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!